TrialClinical pharmacology and therapeutics2021

COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia.

Garth W Strohbehn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.